Immunocore Holdings (IMCR) Other Non-Current Assets (2019 - 2026)

Immunocore Holdings' (IMCR) quarterly Other Non-Current Assets came in at $18.6 million in Q1 2026, up 8.65% year-on-year from $17.1 million in Q1 2025, and down 8.22% quarter-over-quarter from $20.3 million in Q4 2025.

Immunocore Holdings (IMCR) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Immunocore Holdings has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $18.6 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $18.6 million, up 8.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.6 million (up 8.65% YoY), and the FY2025 annual result was $20.3 million, up 18.49% from the prior year.
  • Other Non-Current Assets came in at $18.6 million for Q1 2026 at Immunocore Holdings, down from $20.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $20.3 million in Q4 2025 to a low of $1.1 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $17.0 million (2025), against an average of $15.6 million.
  • Across the five-year window, Other Non-Current Assets soared 1211.29% in 2023 and slipped 4.35% in 2025, its largest moves.
  • Immunocore Holdings' Other Non-Current Assets stood at $1.1 million in 2022, then jumped by 1211.29% to $14.5 million in 2023, then increased by 18.27% to $17.1 million in 2024, then climbed by 18.49% to $20.3 million in 2025, then retreated by 8.22% to $18.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $18.6 million (Q1 2026), $20.3 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - -
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - 60,000.00
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn 1.26 Bn
9 Abivax 93.46 Bn 93.46 Bn - -
10 Immunocore Holdings 1.46 Bn 616.35 Mn 106.24 Mn 18.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.61 Mn
Dec 31, 2025 20.28 Mn
Sep 30, 2025 16.49 Mn
Jun 30, 2025 17.04 Mn
Mar 31, 2025 17.13 Mn
Dec 31, 2024 17.12 Mn
Sep 30, 2024 17.24 Mn
Jun 30, 2024 16.28 Mn
Mar 31, 2024 16.00 Mn
Dec 31, 2023 14.47 Mn
Dec 31, 2022 1.10 Mn
Dec 31, 2021 1.06 Mn
Dec 31, 2020 1.04 Mn
Dec 31, 2019 5.64 Mn